ATE420106T1 - Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung - Google Patents
Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendungInfo
- Publication number
- ATE420106T1 ATE420106T1 AT99954126T AT99954126T ATE420106T1 AT E420106 T1 ATE420106 T1 AT E420106T1 AT 99954126 T AT99954126 T AT 99954126T AT 99954126 T AT99954126 T AT 99954126T AT E420106 T1 ATE420106 T1 AT E420106T1
- Authority
- AT
- Austria
- Prior art keywords
- code
- dna fragments
- chlamydia
- chlamydia antigen
- strain
- Prior art date
Links
- 241000606161 Chlamydia Species 0.000 title abstract 2
- 239000000427 antigen Substances 0.000 title 1
- 102000036639 antigens Human genes 0.000 title 1
- 108091007433 antigens Proteins 0.000 title 1
- 239000012634 fragment Substances 0.000 title 1
- 241001647372 Chlamydia pneumoniae Species 0.000 abstract 2
- 239000002243 precursor Substances 0.000 abstract 2
- 108090000623 proteins and genes Proteins 0.000 abstract 2
- -1 DNA Chemical class 0.000 abstract 1
- 201000010099 disease Diseases 0.000 abstract 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 230000003053 immunization Effects 0.000 abstract 1
- 238000002649 immunization Methods 0.000 abstract 1
- 208000015181 infectious disease Diseases 0.000 abstract 1
- 238000000034 method Methods 0.000 abstract 1
- 238000012986 modification Methods 0.000 abstract 1
- 230000004048 modification Effects 0.000 abstract 1
- 102000039446 nucleic acids Human genes 0.000 abstract 1
- 108020004707 nucleic acids Proteins 0.000 abstract 1
- 150000007523 nucleic acids Chemical class 0.000 abstract 1
- 239000002773 nucleotide Substances 0.000 abstract 1
- 125000003729 nucleotide group Chemical group 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/295—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Chlamydiales (O)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P11/00—Drugs for disorders of the respiratory system
- A61P11/06—Antiasthmatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/53—DNA (RNA) vaccination
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/01—Fusion polypeptide containing a localisation/targetting motif
- C07K2319/02—Fusion polypeptide containing a localisation/targetting motif containing a signal sequence
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Pulmonology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biochemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Molecular Biology (AREA)
- Genetics & Genomics (AREA)
- Biophysics (AREA)
- Communicable Diseases (AREA)
- Urology & Nephrology (AREA)
- Heart & Thoracic Surgery (AREA)
- Cardiology (AREA)
- Vascular Medicine (AREA)
- Oncology (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Peptides Or Proteins (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Saccharide Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US10659098P | 1998-11-02 | 1998-11-02 | |
| US13307199P | 1999-05-07 | 1999-05-07 | |
| US09/430,723 US6607730B1 (en) | 1998-11-02 | 1999-10-29 | Chlamydia antigens and corresponding DNA fragments and uses thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE420106T1 true ATE420106T1 (de) | 2009-01-15 |
Family
ID=27380151
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT99954126T ATE420106T1 (de) | 1998-11-02 | 1999-11-02 | Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US6607730B1 (de) |
| EP (1) | EP1127065B1 (de) |
| JP (1) | JP2002530054A (de) |
| AT (1) | ATE420106T1 (de) |
| AU (1) | AU753984B2 (de) |
| CA (1) | CA2349504A1 (de) |
| DE (1) | DE69940268D1 (de) |
| NZ (1) | NZ511889A (de) |
| WO (1) | WO2000026239A2 (de) |
Families Citing this family (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU772356B2 (en) * | 1998-12-04 | 2004-04-22 | Aventis Pasteur Limited | Two-step immunization procedure against chlamydia infection |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| JP2003507433A (ja) * | 1999-08-20 | 2003-02-25 | ザ ゼネラル ホスピタル コーポレーション | 敗血症治療において治療に用いる対象としての外膜タンパク質ａ、ペプチドグリカン関連リポタンパク質およびムレインリポタンパク質 |
| DE60044146D1 (de) * | 1999-12-22 | 2010-05-20 | Aventis Pasteur | D ihre verwendungen |
| GB0103169D0 (en) * | 2001-02-08 | 2001-03-28 | Smithkline Beecham Biolog | Vaccine composition |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20010032336A (ko) | 1997-11-21 | 2001-04-16 | 브랑디 빠스깔 | 클라미디아 뉴모니아 게놈 서열과 폴리펩티드, 이의 단편및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| KR100735651B1 (ko) | 1997-11-28 | 2007-07-06 | 세로노 제네틱스 인스티튜트 에스.에이. | 클라미디아 트라코마티스 게놈 서열과 폴리펩티드, 이의단편 및 이의 용도, 특히, 감염의 진단, 예방 및 치료 용도 |
| JP2002529069A (ja) | 1998-11-12 | 2002-09-10 | ザ リージェンツ オブ ザ ユニバーシティ オブ カリフォルニア | クラミジア・ニューモニエのゲノム配列 |
| KR20100132086A (ko) | 1998-12-08 | 2010-12-16 | 코릭사 코포레이션 | 클라미디아 감염을 치료 및 진단하기 위한 조성물 및 이를 포함하는 약제학적 조성물 및 진단 키트 |
| US20020061848A1 (en) | 2000-07-20 | 2002-05-23 | Ajay Bhatia | Compounds and methods for treatment and diagnosis of chlamydial infection |
| US6565856B1 (en) | 1998-12-08 | 2003-05-20 | Corixa Corporation | Compounds and methods for treatment and diagnosis of chlamydial infection |
| GB9828000D0 (en) | 1998-12-18 | 1999-02-10 | Chiron Spa | Antigens |
| GB9902555D0 (en) | 1999-02-05 | 1999-03-24 | Neutec Pharma Plc | Medicament |
| CA2373021A1 (en) | 1999-05-03 | 2000-11-09 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| NZ517952A (en) | 1999-09-20 | 2004-01-30 | Aventis Pasteur | Chlamydia antigens and corresponding DNA fragments and uses thereof |
| US6632663B1 (en) | 1999-09-22 | 2003-10-14 | Aventis Pasteur Limited | DNA immunization against chlamydia infection |
| DE60044146D1 (de) | 1999-12-22 | 2010-05-20 | Aventis Pasteur | D ihre verwendungen |
| EP1278855B1 (de) | 2000-04-21 | 2008-03-12 | Corixa Corporation | Verbindungen und verfahren zur behandlung und diagnose von chlamydia-infektionen |
| AU2001258105A1 (en) | 2000-05-08 | 2001-11-20 | Aventis Pasteur Limited | Chlamydia antigens and corresponding dna fragments and uses thereof |
| WO2002002606A2 (en) | 2000-07-03 | 2002-01-10 | Chiron S.P.A. | Immunisation against chlamydia pneumoniae |
-
1999
- 1999-10-29 US US09/430,723 patent/US6607730B1/en not_active Expired - Fee Related
- 1999-11-02 CA CA002349504A patent/CA2349504A1/en not_active Abandoned
- 1999-11-02 AT AT99954126T patent/ATE420106T1/de not_active IP Right Cessation
- 1999-11-02 WO PCT/GB1999/003622 patent/WO2000026239A2/en not_active Ceased
- 1999-11-02 DE DE69940268T patent/DE69940268D1/de not_active Expired - Fee Related
- 1999-11-02 EP EP99954126A patent/EP1127065B1/de not_active Expired - Lifetime
- 1999-11-02 NZ NZ511889A patent/NZ511889A/en not_active IP Right Cessation
- 1999-11-02 JP JP2000579626A patent/JP2002530054A/ja active Pending
- 1999-11-02 AU AU10565/00A patent/AU753984B2/en not_active Ceased
-
2003
- 2003-01-28 US US10/352,618 patent/US20040022801A1/en not_active Abandoned
Also Published As
| Publication number | Publication date |
|---|---|
| AU1056500A (en) | 2000-05-22 |
| NZ511889A (en) | 2003-12-19 |
| AU753984B2 (en) | 2002-10-31 |
| EP1127065B1 (de) | 2009-01-07 |
| WO2000026239A2 (en) | 2000-05-11 |
| JP2002530054A (ja) | 2002-09-17 |
| US20040022801A1 (en) | 2004-02-05 |
| CA2349504A1 (en) | 2000-05-11 |
| US6607730B1 (en) | 2003-08-19 |
| EP1127065A2 (de) | 2001-08-29 |
| DE69940268D1 (de) | 2009-02-26 |
| WO2000026239A3 (en) | 2000-08-10 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2001046224A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2000066739A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2002074979A3 (en) | Expression profiles and methods of use | |
| HUP0402271A2 (hu) | Pseudoplectania nigrellá-ból származó antimikrobiális polipeptidek | |
| WO2001070174A8 (en) | Vegf-modulated genes and methods employing them | |
| DE69634412D1 (de) | Regulierte gene und ihre verwendungen | |
| BR9813608B1 (pt) | célula hospedeira de bacillus transgênica, e, processo para produzir um polipeptìdeo tendo atividade aminopeptidase. | |
| WO2003093316A3 (en) | Immunoglobulin-domain containing cell surface recognition molecules | |
| WO2001046225A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2002040668A3 (de) | Proteine und den proteinen zugrundeliegende dna-sequenzen mit funktion bei entzündungsereignissen | |
| WO2001075111A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075112A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075113A3 (en) | Chlamydia myosin heavy chain homolog as antigen, corresponding dna fragments and uses thereof | |
| DE60041042D1 (de) | Chlamydia antigene und deren korrespondierende dna fragmente und verwendungen davon | |
| WO2001074863A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| WO2001075114A3 (en) | Chlamydia transmembrane protein as antigen, corresponding dna fragments and uses thereof | |
| ATE420106T1 (de) | Chlamydia antigen, dns fragmente welche für solche kodieren und deren verwendung | |
| WO1999010504A3 (en) | Caspase-14, an apoptotic protease, nucleic acids encoding and methods of use | |
| WO2001046226A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| MXPA01004353A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| WO2000006742A3 (en) | Chlamydia antigens and corresponding dna fragments and uses thereof | |
| HK1039793A1 (zh) | 一種細胞凋亡蛋白酶天冬氨酸特異性半胱氨酸蛋白酶-14，編碼核酸及其使用方法 | |
| MXPA01001639A (es) | Antigenos de chlamydia y los correspondientes fragmentos de adn y usos de los mismos. | |
| ATE384738T1 (de) | Chlamydia antigene, entsprechende dna fragmente und ihre verwendungen | |
| CA2628354A1 (en) | Organic cation transporter genes |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |